Methodology

All entries for: ReviR Therapeutics

September 30, 2025

ReviR Therapeutics

Orphan Drug Designation

FDA orphan drug designation: treatment of Charcot-Marie-Tooth disease

Disease Area: Rare Diseases
Source
Facebook Linkedin
Main Menu
Scroll to Top